Blueweave
South Africa In Vitro Diagnostics Devices Market

South Africa In Vitro Diagnostics Devices Market

SPECIAL OFFER : 25% Super Discount For All !

South Africa In-Vitro Diagnostics (IVD) Devices Market - By Type (Product, Service); By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology); By Application (Oncology, Infectious Disease, Diabetes, Cardiology, Nephrology); By End User (Hospitals, Point of Care Testing, Laboratories, Academic Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

  • Published Date: March 2023
  • Report ID: BWC23228
  • Available Format: PDF
  • Page: 260

Report Overview

Growing prevalence of chronic and infectious diseases in geriatric population and rising awareness of early disease diagnosis are projected to propel the expansion of South Africa In Vitro Diagnostics Devices Market during the forecast period between 2023 and 2029.

South Africa In-Vitro Diagnostics Devices Market - Industry Trends & Forecast Report, 2029

South Africa in vitro diagnostic (IVD) devices market size was estimated at USD 548.22 million in 2022. During the forecast period between 2023 and 2029, the size of South Africa in vitro diagnostics devices market is projected to grow at a CAGR of 8.21% reaching a value of USD 945.6 million by 2029. Major growth drivers for South Africa in vitro diagnostics devices market include increasing need for accurate and efficient diagnostic tests, expanding the usage of point-of-care diagnostics in the country, increasing technology improvements in the diagnostics market and increasing prevalence of chronic diseases. Based on a PubMed Central article published in July 2022, about 7.9 million people in South Africa are infected with HIV, with a nationwide prevalence rate of 14% across all age groups. As HIV-positive people are more vulnerable to a variety of chronic and infectious diseases, the country's demand for in-vitro diagnostic tools for diagnosis and monitoring is expected to boost the demand for market. Also, according to the International Diabetes Federation's (IDF) 2021 report, the number of South African adults aged 20-79 years with diabetes is projected to rise from 4.2 million in 2021 to 7.5 million by 2045. As a result of this significant and growing disease burden, the demand for in-vitro diagnostic tests and products in South Africa is expected to increase, leading to growth in the in-vitro diagnostics market during the forecast period. Also, the IVD market is expanding owing to the implementation of advanced technologies such as PCR, NGS, genetic testing, and molecular diagnostics. This has resulted in a shift from conventional diagnostic methods to modern generation that operates at the genetic level. Advanced technologies have played a crucial role in enabling this transition in the IVD industry. Hence, such factors have fueled the expansion of South Africa in vitro diagnostics (IVD) market during the period in analysis.

South Africa In Vitro Diagnostics Devices Market

South Africa In Vitro Diagnostics Devices Market – Overview

In Vitro Diagnostics (IVD) refer to tests conducted on samples such as blood or tissue that have been extracted from the human body. These diagnostics are used to detect diseases or other health conditions, monitor a person's overall health, and assist in treating illnesses. In precision medicine, IVDs are also used to identify patients who are likely to benefit from particular treatments or therapies. Next-generation sequencing tests are an example of IVDs that screen an individual's DNA to detect genomic variations. IVDs are critical tools for everyday medical practice and emergencies, and numerous treatment decisions are based on their results. The development and availability of laboratory capacity are crucial for effective healthcare delivery worldwide. In-vitro diagnostic point-of-care testing is needed to speed up patient management and improve access to services. This testing involves directly measuring an analyte in a patient's sample at the hospital without sending it to a laboratory. This approach can offer several benefits, including faster results and robust interventions. The development of condition-specific markers is expected to have a significant impact on the market economy.

South Africa In Vitro Diagnostics Devices Market

Growth Drivers

Growing Prevalence of Chronic & Infectious Diseases in Geriatric Population

The increasing prevalence of chronic and infectious diseases in the elderly population is expected to fuel the growth of the in vitro diagnostics market in South Africa. This is due to the fact that elderly individuals are more prone to developing a range of diseases, such as HIV, diabetes, cancer, and cardiovascular diseases, which require regular monitoring and diagnosis. In vitro diagnostics tests are critical tools for detecting, diagnosing, and managing these conditions, thereby providing an opportunity for the market to expand. Moreover, the rising geriatric population in South Africa, coupled with increasing life expectancy, is expected to drive the demand for in vitro diagnostics products over the forecast period. This trend is expected to further contribute to the growth of the market as a larger population requires more medical attention and diagnostic services.

Restraints

High Investments Deterring Customers from Adopting Technologies

South Africa in vitro diagnostics devices market growth may face a potential obstacle due to high investment costs, which can discourage customers from adopting the latest diagnostic technologies. High capital investment requirements may deter small and medium-sized laboratories from acquiring new equipment, which can impede the growth of the market. This challenge may particularly affect the adoption of advanced technologies such as molecular diagnostics, next-generation sequencing, and genetic testing, which require significant investments in equipment, infrastructure, and training. In addition, strict regulatory requirements and the need for skilled personnel may also add to the cost burden for laboratory operators.

Impact of COVID -19 on South Africa In Vitro Diagnostics Devices Market

COVID-19 pandemic spurred global demand for in-vitro diagnostic (IVD) goods like as test kits and reagents for the rapid and precise identification of SARS-CoV2 virus infection. The pandemic underlined the importance of IVDs in detecting infectious diseases, notably COVID-19, and testing was regarded as a vital step in pandemic control. During the pandemic, the IVD market witnessed a beneficial impact, owing principally to the rapid release of COVID-19 diagnostic kits by key companies. The World Health Organization raised the number of laboratories equipped to identify COVID-19 to over 900, and genetic sequencing efforts in Africa were enhanced, leading to a rise in sequencing data on the continent. The IVD market lost some traction during post pandemic, but it is predicted to develop steadily during the forecast period.

South Africa In Vitro Diagnostics Devices Market

Segmental Coverage

South Africa In Vitro Diagnostics Devices Market – By Type

By type, South Africa in vitro diagnostics devices market is bifurcated into Product and Service segments. The product segment includes reagents & kits and instruments. The reagents and kits subsegment is expected to hold a higher market share. Reagents are an essential component of in-vitro diagnostics. Reagents are an essential component of in-vitro diagnostics. They have a wide range of applications for various sorts of disease diagnosis. The diagnosis of COVID-19 infection was expected to significantly contribute to the expansion of the researched segment due to the increased need for reagents to meet the expanding diagnostics demand worldwide. Few market participants purchased COVID-19 testing reagents. For example, the Health Republic of South Africa published a revised policy and guidelines for SARS-COV-2 in-vitro diagnostic testing in South Africa in July 2021.

South Africa In Vitro Diagnostics Devices Market – By Technology

Based on technology, South Africa in vitro diagnostics devices market is divided into Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, and Microbiology segments. The molecular diagnostics segment is expected to dominate the market during the forecast period. Rising breakthroughs in the field of molecular diagnostics, rising prevalence of infectious disorders, and rising use of molecular diagnostic tests are the primary drivers driving the segment's growth. The rising prevalence of infectious diseases, such as influenza and HIV, is driving the use of molecular diagnostic testing in the region. Also, the introduction of innovative technologies in the field of molecular diagnostics will boost the segment's growth. CRISPR-Cas13 is a unique molecular diagnostic technology that uses programmable RNA to generate a sensitive and specific method with high base precision, resulting in a breakthrough tool for the quick identification of microbes. As a result, factors such as rising prevalence of infectious diseases, such as influenza and HIV, as well as the development of new technologies in the molecular diagnostic sector, are predicted to boost segment growth.

South Africa In Vitro Diagnostics Devices Market – By Application

Based on application, South Africa in vitro diagnostics devices market is segmented into Oncology, Infectious Disease, Diabetes, Cardiology, and Nephrology. The infectious diseases segment is expected to account for the highest share of the in-vitro diagnostics market during the forecast period. The increased occurrence of infectious diseases and multi-drug-resistant infectious diseases around the world, as well as the increasing demands for practical diagnostic tools for these diseases, can be attributed to the sector's considerable contribution.

South Africa In Vitro Diagnostics Devices Market – By End User

Based on end user, South Africa in vitro diagnostics devices market is divided into Hospitals, Point of Care Testing, Laboratories, and Academic Institutes segments.

Competitive Landscape

Major players operating in South Africa In Vitro Diagnostics Devices Market include Abbott, Danaher, Siemens Healthineers AG, Roche Diagnostics, Sysmex Corporation, Beckman Coulter South Africa, and Mindray South Africa. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

South Africa

Product/ Service Segmentation

Type, Technology, Application, End User

Key Players

Abbott, Danaher, Siemens Healthineers AG, Roche Diagnostics, Sysmex Corporation, Beckman Coulter South Africa, Mindray South Africa

 

By Type

  • Product

  • Service

By Technology

  • Clinical Chemistry

  • Immunoassay/ Immunochemistry

  • Molecular Diagnostics

  • Hematology

  • Microbiology

By Application

  • Oncology

  • Infectious Disease

  • Diabetes

  • Cardiology

  • Nephrology

By End User

  • Hospitals

  • Point of Care Testing

  • Laboratories

  • Academic Institutes

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. South Africa In-Vitro Diagnostics Devices (IVD) Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing Prevalence of Chronic and Infectious Diseases in Geriatric Population
        2. Rising Awareness of Early Disease Diagnosis
      2. Restraints
        1. High Investment Deterring the Customers from Adopting Technologies
      3. Opportunities
        1. Advancements in Technology
      4. Challenges
        1. Stringent Government Regulations
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. South Africa In-Vitro Diagnostics Devices (IVD) Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
        1. Product
          1. Reagents & Kits
          2. Instruments
        2. Service
          1. Software
          2. Testing Services
      1. By Technology
        1. Clinical Chemistry
        2. Immunoassay/ Immunochemistry
        3. Molecular Diagnostics
        4. Hematology
        5. Microbiology
        6. Others (Coagulation & Hemostasis, Urinalysis)
      2. By Application
        1. Oncology
        2. Infectious Disease
        3. Diabetes
        4. Cardiology
        5. Nephrology
        6. Others (Autoimmune disease, Drug testing/ pharmacogenomics)
      3. By End User
        1. Hospitals
        2. Point of Care Testing
        3. Laboratories
        4. Academic Institutes
  5. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. South Africa In Vitro Diagnostics (IVD) Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

 

  1. Impact of Covid-19 on South Africa In-Vitro Diagnostics Devices (IVD) Market
  2. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Abbott
    2. Danaher
    3. Siemens Healthineers AG
    4. Roche Diagnostics
    5. Sysmex Corporation
    6. Beckman Coulter South Africa
    7. Mindray South Africa
    8. Other Prominent Players
  3. Key Strategic Recommendations
  4. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

 

List of Figures

 

Figure 1       South Africa In Vitro Diagnostics (IVD) Segmentation

Figure 2       South Africa In-Vitro Diagnostics Devices (IVD) Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       South Africa In-Vitro Diagnostics Devices (IVD) Market Size, By Value (USD Million), 2019–2029

Figure 5       South Africa In-Vitro Diagnostics Devices (IVD) Market Share, By Type, By Value, 2019–2029

Figure 6       South Africa In-Vitro Diagnostics Devices (IVD) Market Share, By Technology, By Value, 2019–2029

Figure 7       South Africa In-Vitro Diagnostics Devices (IVD) Market Share, By Application, By Value, 2019–2029

Figure 8       South Africa In-Vitro Diagnostics Devices (IVD) Market Share, By End User, By Value, 2019–2029

 

List of Tables

 

Table 1        South Africa In-Vitro Diagnostics Devices (IVD) Market Size, By Value (USD Million), 2019–2029

Table 2        South Africa In-Vitro Diagnostics Devices (IVD) Market Size, By Type, By Value, 2019–2029

Table 3        South Africa In-Vitro Diagnostics Devices (IVD) Market Size, By Technology, By Value, 2019–2029

Table 4        South Africa In-Vitro Diagnostics Devices (IVD) Market Size, By Application, By Value, 2019–2029

Table 5        South Africa In-Vitro Diagnostics Devices (IVD) Market Size, By End User, By Value, 2019–2029

Table 6        Abbott Company Overview

Table 7        Abbott Financial Overview

Table 8        Danaher Company Overview

Table 9        Danaher Financial Overview

Table 10      Siemens Healthineers AG Company Overview

Table 11      Siemens Healthineers AG Financial Overview

Table 12      Roche Diagnostics Company Overview

Table 13      Roche Diagnostics Financial Overview

Table 14      Sysmex Corporation Company Overview

Table 15      Sysmex Corporation Financial Overview

Table 16    Beckman Coulter South Africa

Table 17    Beckman Coulter South Africa

Table 18    Mindray South Africa

Table 19    Mindray South Africa

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The molecular diagnostics segment is expected to hold the highest market share in South Africa In Vitro Diagnostics Devices Market by technology.
Ans: South Africa In Vitro Diagnostics Devices Market size was estimated at USD 548.22 million in 2022.
Ans: Major factors driving the growth of South Africa In Vitro Diagnostics Devices Market include growing prevalence of chronic and infectious diseases in geriatric population and rising awareness of early disease diagnosis.
Ans: Key players in South Africa In Vitro Diagnostics Devices Market include Abbott, Danaher, Siemens Healthineers AG, Roche Diagnostics, Sysmex Corporation, Beckman Coulter South Africa, and Mindray South Africa.
Ans: The product segment is expected to hold the highest market share in South Africa In Vitro Diagnostics Devices Market by type.